Deborah S. Yokoe*

, Gary A. Noskin†, Susan M. Cunningham†, Gianna Zuccotti‡, Theresa Plaskett‡, Victoria J. Fraser§, Margaret A. Olsen§, Jerome I. Tokars¶, Steven Solomon¶, Trish M. Perl#, Sara E. Cosgrove#, Richard S. Tilson*, Maurice Greenbaum**, David C. Hooper††, Kenneth E. Sands‡‡, John Tully§§, Loreen A. Herwaldt¶¶, Daniel J. Diekema¶¶, Edward S. Wong##, Michael Climo##, and Richard Platt***
Author affiliations: *Brigham and Women's Hospital, Boston, Massachusetts, USA; †Northwestern University, Chicago, Illinois, USA; ‡Memorial Sloan-Kettering Cancer Center, New York, New York, USA; §Washington University School of Medicine, St. Louis, Missouri, USA; ¶Centers for Disease Control and Prevention, Atlanta, Georgia, USA; #Johns Hopkins Medical Institutions, Baltimore, Maryland, USA; **North Shore Medical Center-Salem Hospital, Salem, Massachusetts, USA; ††Massachusetts General Hospital, Boston, Massachusetts, USA; ‡‡Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; §§Mount Auburn Medical Center, Cambridge, Massachusetts, USA; ¶¶University of Iowa Carver College of Medicine, Iowa City, Iowa, USA; ##McGuire Veterans Affairs Medical Center, Richmond, Virginia, USA; ***Harvard Pilgrim Health Care, Boston, Massachusetts, USA
Main Article
Table A2
SSI ratesa after CABG proceduresb,c
| Hospital |
SSI rates based on (%)
|
| Routine surveillance |
Any method (routine, antimicrobial
exposure, discharge diagnoses) |
| 1A |
2.2 |
2.6 |
| 1B |
2.3 |
3.5 |
| 1C |
5.9 |
7.4 |
| 1D |
7.7 |
9.9 |
| Phase 1 pooled (SSI/procedures) |
4.9 (112/2,267) |
6.3 (142/2,267) |
| 2A |
2.4 |
6.1 |
| 2B |
2.5 |
6.6 |
| 2C |
3.5 |
6.0 |
| 2D |
5.3 |
8.2 |
| 2E |
6.1 |
9.6 |
| 2F |
6.5 |
8.8 |
| Phase 2 pooled (SSI/procedures) |
4.6 (298/6,472) |
7.7 (501/6,472) |
Main Article
Top of Page